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Objectives: Some patients with hypertrophic cardiomyopathy (HCM) develop left ventricular apical
aneurysm, leading to serious cardiovascular complications. The aims of this study were to identify the
incidence and clinical course of HCM patients with apical aneurysms in Japan, and to evaluate the role of
electrocardiography (ECG) as a screening test to detect apical aneurysms in HCM patients.
Methods and results: In a retrospective, single center analysis of a population of 247 HCM patients, 21
patients (8.5%) had left ventricular apical aneurysms. Their mean age was 60±14 years (range: 23–77
years) at study entry. Over 4.7±3.3 years of follow-up, 10patients (47.6%) experienced an adverse clinical
event (annual event rate: 10.1%/y), including ﬁve implantable cardioverter-deﬁbrillator (ICD) implan-
tations for ventricular tachycardia/ventricular ﬁbrillation (VT/VF), an appropriate discharge of ICD for
VT/VF, and four nonfatal thromboembolic strokes. Two patients developed systolic dysfunction (ejection
fraction <50%). No sudden cardiac death or progressive heart failure was detected. Fourteen patients
showed ST-segment elevation (≥1mm) in V3 through V5 of ECG. In four patients, progression of the ST-
segmentelevationwas recognized.When theST-segmentelevationwasused to identify apical aneurysms
in HCM patients, the sensitivity was 66.7%, and the speciﬁcity was 98.7%.
Conclusion: Apical aneurysms in HCM patients in Japan are not rare, and are associated with serious
cardiovascular complications. The early diagnosis of apical aneurysms can be achieved by serial ECG.
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Hypertrophic cardiomyopathy (HCM) has a broad spectrum of
orphological features, clinical expressions, natural history, and
rognosis [1–5]. Some patients with hypertrophic cardiomyopa-
hy develop left ventricular apical aneurysm (LVAA), leading to
erious cardiovascular complications (left ventricular thrombosis
nd embolization, arrhythmia, sudden death). One report showed
hat the prevalence of LVAA in all non-Japanese HCM case was
.2% [6]. However, there is a possibility that this subgroup has
emainedunderappreciated [6,7] and theprevalence in all Japanese
CM patients was unclear. Cardiac magnetic resonance (CMR) is a
on-invasive standard method that can be used to assess LV func-
ion, mass, and volume as well as to qualify the wall thickness,
nd dimension [8–10]. CMR has limitations, and is not effective
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for patients with arrhythmia, pacemakers, or other implantable
devices. Echocardiography is another non-invasive tool to evalu-
ate HCM patients, but this tool also has a limitation for visualizing
the apical portion of left ventricle.
In this study, we evaluated the incidence, clinical course, and
prognosis of Japanese HCM patients with LVAA. In addition, we
identiﬁed the role of electrocardiography (ECG) in the early diag-
nosis of LVAA in HCM patients.
Methods
Study patients
The study population included 247 patients (161 male and 86
female) with clinically diagnosed HCM who were consecutively
enrolled and evaluated from January 2005 to December 2010 at
Jichi Medical Hospital.
Patients were excluded if they fulﬁlled any of the following:
obstructive atherosclerotic coronary artery disease as a cause of
LVAA formation, signiﬁcant coronary arterial narrowing (>50%
served.
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tenosis) in the left anterior descending artery by conventional
rteriography or cardiac computed tomography angiogram, a his-
ory of chest pain, old myocardial infarction, and acute coronary
yndrome. Twopatientswere excluded because of signiﬁcant coro-
ary arterial narrowing and history of chest pain. Data on survival
nd the clinical status of patientswere obtained either during serial
linic visits or by direct communication with patients.
All patients provided their informed consent, in which patients
greed to the use of their medical information for research pur-
oses. The ethics committee of the internal review board of Jichi
edical University School of Medicine, Tochigi, Japan, approved
he protocol.
iagnosis of LVAA
The diagnosis of HCM was based on echocardiographic docu-
entation of a hypertrophied, non-dilated LV in the absence of
nother cardiac or systemic disease that could account for the
ypertrophy [11]. A LVAA was deﬁned as a discrete thin-walled
yskinetic or akinetic segment of the most distal portion of the
hamber with a relatively wide communication to the LV cavity
6,12–14].
lectrocardiography
Twelve-lead ECG was reviewed during the evaluation. The ECG
ata were recorded on paper at 25mm/s with a standardization
f 10mm=1mV. An ambulatory 24-h Holter ECG analysis was
ecorded for at least 24h. Nonsustained ventricular tachycardia
VT) was deﬁned as at least three consecutive ventricular prema-
ure beats of >120 beats/min.
chocardiography
Two-dimensional and Doppler transthoracic echocardiography
ere performed for each patient using commercially available
nstruments by the same expert echocardiography examiners, who
ere blinded to the clinical status of the patients. The anatomic
nd Doppler measurements were performed according to the
able 1
linical data from 21 hypertrophic cardiomyopathy patients with left ventricular apical a
Pat Age (y) Gen NYHA Size
(mm)
Max LV
thickness
(mm)
LVED
(mm)
LAD
(mm)
EF (%) Arry
1 66 F 2 20×28 20 42 34 62 nsV
2 45 M 1 21×15 21 42 38 58 −
3 61 M 2 20×10 17 51 43 66 nsV
4 72 M 1 12×23 19 49 52 76 nsV
5 67 M 2 24×22 23 53 45 49.8 VT
6 75 M 2 22×8 15 40 61 50 VT/V
7 47 F 2 35×17 22 47 40 63 nsV
8 71 F 2 21×12 19 48 51 58 VF,
9 55 M 2 18×10 18 43 40.9 69.1 pAF
10 23 M 2 6×9 21 35 37 77 −
11 60 F 1 18×10 21 40 38.5 66.8 −
12 61 F 2 20×7 13 35 43 67 −
13 65 F 1 18×18 18 42 35 78.6 nsV
14 32 F 1 18×10 20 34 36 86 −
15 64 F 2 11×5 21 45 43 63 −
16 71 F 2 13×5 23 41 54 49.3 nsV
17 71 M 1 20×15 18 49 46 70.9 −
18 75 M 2 38×18 18 55 48 69 VT
19 67 M 2 34×20 23 52 47 68.8 VT
20 77 M 1 22×10 19 47 37 77.3 −
21 54 M 1 12×5 25 51 42 72 −
at, patients; Gen, Gender; NYHA, NYHA functional class; Size, size of aneurysm; LV, left ve
raction; Arry, arrhythmia; nsVT, non-sustained ventricular tachycardia; AF atrial ﬁbrillat
levation; Jet Flow, diastolic paradoxic jet ﬂow; CA, coronary angiography; CT, computedology 64 (2014) 265–272
recommendations of the American Society of Echocardiography
[15]. The LV ejection fraction (EF) was calculated with a modiﬁed
Simpson’s rule. The magnitude of the LVH and outﬂow obstruction
was assessed as previously described [16–18]. Flow velocity pro-
ﬁles were obtained from apical projections of pulsedwave Doppler
(transmitral ﬂow and LV outﬂow tract). The paradoxic jet ﬂow in
the LV was deﬁned as previously described [19]. The diagnostic
criteria for apical HCM included the demonstration of asymmetric
LVH, which was predominantly conﬁned to the LV apex, with an
apical wall thickness ≥15mm and a ratio of the maximal apical to
posterior wall thickness ≥1.5, based on two-dimensional echocar-
diography [20].
Statistical analyses
Categorical variables are expressed as absolute values and
percentages (%). Continuous variables are reported as the mean
values± standard deviation (SD). Differences in the categorized
variables were compared by the use of the Chi-square test. Contin-
uous normally distributed data were compared by use of unpaired
Student’s t-tests. The annual event rate was calculated as the num-
ber of adverse clinical events divided by the total observation
time of the cohort starting from the time of the ﬁrst evalua-
tion. Statistical analyses were performed with the SPSS software
package, version16.0J (SAS Institute Inc., Cary, NC, USA). To evalu-
ate the accuracy of ECG and echocardiography for identifying apical
aneurysms in HCM patients, we generated a two-by-two table of
apical aneurysms (+/−) versus ST-segment elevation in V3–V5 of
ECG or the diastolic paradoxic jet ﬂow of echocardiography. Using
this table, the sensitivity, speciﬁcity, positive and negative predic-
tive values, and likelihood ratios were calculated with standard
formulas.
ResultsClinical proﬁle
LVAAswere identiﬁed in21 (8.5%) of 247HCMpatients (Table1).
The 21 patients were 60±14 years of age (range: 23–77 years)
neurysm.
Q in
V3–V5
Max R wave
in V3–V5
(mm)
STE Jet
ﬂow
CA and
CT
Outcome
T + 1 + − + CI, LV thrombus, alive
− 16 − − − Alive
T − 36 + + − Alive
T, AF − 18 + + − CI, alive
+ 5 + + + ICD, alive
F − 6 + + + ICD, alive
T − 8 + − + CI, LV thrombus, alive
AF − 39.5 − + + ICD, alive
− 42 − − − Alive
− 32 − − − Alive
+ 12 + − − Alive
− 36 + − − Alive
T − 14 + + − Alive
− 9 + − − Alive
− 43 − − − Syncope, alive
T − 55 − + − Syncope, alive
+ 1 + − − Alive
− 0 + − + ICD, LV thrombus, alive
− 16 + + − CI, ICD, alive
− 12 + − − Alive
− 48 − + − Alive
ntricular; LVED, LV end-diastolic dimension; LAD, left atrial dimension; EF, ejection
ion; pAF, paroxysmal atrial ﬁbrillation; VF, ventricular ﬁbrillation; STE, ST-segment
tomography; CI, cerebral infarction; ICD, implantable cardioverter-deﬁbrillator.
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t study entry. Twelve patients (57.1%) were male. At the most
ecent evaluation, eight patients (38.0%) were asymptomatic [New
ork Heart Association (NYHA) functional class I] and 13 (61.9%)
eremildly symptomatic (NYHAclass II). No severely symptomatic
atient was encountered (NYHA classes III–IV). Two patients had
family history of HCM, and a family history of sudden death was
oted for one patient.
When the 21 apical aneurysm HCM patients were compared
ith the 226 non-apical aneurysm HCM patients at study entry,
here were no differences with respect to gender (male, 57.1%
ersus 65.4%, p=0.55%) and age (60±14 versus 62±12 years;
= 0.50).
CG
Three of the 21 HCM patients with LVAA had atrial ﬁbrillation.
n 14 (66.7%) of the 21 patients, the ECG demonstrated ST-segment
levation (≥1mm) in V3 through V5. The forms of the QRS wave
nd T wave were variable. Three of these 14 patients showed an
S pattern without T wave inversion in V3 through V5 (Fig. 1A).
ix had a reduction of R wave voltage with T-wave inversion in
3 through V5 (Fig. 1B). Two patients showed high R wave voltage
nd T wave inversion (Fig. 1C). The other three of these 14 patients
howed normal voltage R waves without T wave inversion in V3
hroughV5 (Fig. 1D). The remaining7of 21HCMpatientswith LVAA
ad high R waves and giant negative T waves with down-sloping
T-T segments in leads V3 through V5 (Fig. 1E). In 4 of 14 HCM
atients with LVAA and ST-segment elevation, progression of the
T-segment elevationwas identiﬁed during the observation period
Fig. 2A and B). This progression is full of interesting suggestion
f aneurysm formation. In the 226 HCM patients without LVAA,
nly three patients showed ST-segment elevation in V3 through
5. For the identiﬁcation of LVAAs in HCM patients, the sensitivity
f ST-segment elevation was 66.7% and the speciﬁcity was 98.7%
Table 2).
A Holter ECG was performed for all 21 patients with LVAA. Six
ad non-sustained VT and ﬁve had sustained ventricular tachycar-
ia/ventricular ﬁbrillation (VT/VF) in the Holter ECG. Two patients
ad syncope without documented VT/VF.
chocardiography
The EF averaged 66±9% (range: 49–86%), and the LV diastolic
imension was 44±6mm (range: 34–55mm). The LA dimension
as 43±6mm (range: 34–61mm). The maximal LV thickness was
0±2mm(range: 13–25mm). Nine (42.8%) of the 21HCMpatients
ith LVAA showed diastolic paradoxic jet ﬂow in the LV cavity
Fig. 3A–C). The range of the paradoxic jet ﬂow velocity was from
.0m/s to 3.3m/s. In the 224 HCM patients without LVAA, only one
atient showed diastolic paradoxic jet ﬂow in the LV cavity. The
ensitivity of the diastolic paradoxic ﬂow for identifying LVAAs in
CM patients was 42.9%, and the speciﬁcity was 99.6% (Table 2).
o intraventricular pressure gradients of dynamic LV outﬂow tract
t rest were present in HCM patients with LVAA.
Out of all 247HCMpatients, 67 cases of apical HCM (27.3%)were
dentiﬁed (data not shown). In the 21 HCM patients with LVAA,
he prevalence of apical HCM was 4 (19.0%). Three HCM patients
ith LVAA had a large thrombus within the aneurysm identiﬁed
y echocardiography and did not have a history of atrial ﬁbrilla-
ion/ﬂutter (Fig. 3D).
linical courseOver the follow-up period of 4.7±3.3 years, 10 (47.6%) of
1 HCM patients with LVAA experienced an adverse clinical
vent (Table 1), including the need for appropriate implantableology 64 (2014) 265–272 267
cardioverter-deﬁbrillator (ICD) implantation for VT/VF (n=5),
nonfatal thromboembolic stroke (n=4, including three patients
presenting with LV thrombus), and syncope (n=2, no fatal
arrhythmia was identiﬁed). Two patients also developed systolic
dysfunction (EF <50%). No sudden cardiac death or progressive
heart failurewasdetected. Theannual adverse cardiovascular event
rate was 10.1%/y.
The HCM patients with large LVAA (>2 cm) were more likely to
experience an adverse disease complication (8 of 13, 61.5%) than
patients with small aneurysms (<2 cm; 2 of 8, 25%) (Table 1).
Treatment
Of the 21 patients with LVAA, three were treated with -
blockers and angiotensin-converting enzyme (ACE) inhibitors/
angiotensin II receptor blockers (ARB), nine were treated with -
blockers, and three were treated with ACE inhibitors/ARBs. Six
patients were treated with calcium-channel blockers. No patient
underwent invasive septal reduction therapy. Seven patients were
taking warfarin. Of these seven patients, three had sinus rhythm
and LV apical thrombus when they presented with cerebral infarc-
tion (CI), one with CI and AF, two with VT/VF and LV dysfunction,
and one with AF.
Among ﬁve patients with ICD, one experienced an appropriate
ICD discharge for VT/VF. Six of the HCM patients with LVAA had
non-sustained VT and an ICD was not implanted in these patients
for primary prevention.
Discussion
The present study, although retrospective, showed the preva-
lence and clinical manifestations of LVAAs in Japanese HCM
patients, and demonstrated the strengths of ECG for identifying
LVAAs during follow-up.
The prevalence of LVAA was 2.2% in all non-Japanese HCM
patients [6]. In our 247 consecutive patients with HCM, 21 apical
aneurysms (8.5%)wereobserved.Nakamura et al. reported that 15%
of HCM patients in Japan showed segmental wall motion abnor-
malities including apical aneurysms [19]. This ﬁnding suggests that
apical aneurysms are not rare in Japanese patients with all types of
HCM.
Apical-type HCM was ﬁrst described in Japan as a variant form
of HCM, characterized by myocardial hypertrophy occurring pre-
dominantly in the LV apical portion [21,22]. The prevalence of
apical-type HCM in Japanese patients was reported to range from
30% to 41.1%, and the prevalence in non-Japanese patients was
7% [20,23,24]. The prevalence of apical-type HCM in our 247 HCM
patientswas 67 (27.1%). This report showed therewere 4 aneurysm
formations in 67 apical HCM patients. Although apical-type HCM
patientshada relatively goodprognosis, threeof these fourpatients
had adverse events. The prognosis of apical-type HCM patients
with LVAA was not always preferable. In addition, Eriksson et al.
showed that patients with apical hypertrophic cardiomyopathy
have wall motion abnormalities that varied from a large apical
aneurysm to apical hypokinesis [20]. Coronary angiography was
performed in 10 of the 11 patients with infarction, showing nor-
mal coronary arteries inninepatients. Themechanisms responsible
for ischemia in apical-type HCM are still unclear. Decreased capil-
lary myocardial ratio, small vessel disease, and other mechanisms
may also result in regional apical ischemia and be involved in
development of apical infarction and aneurysm. Apical aneurysms
havebeendescribed innon-apicalHCM, oftenwithmid-ventricular
obstruction. In our 21 HCM patients with LVAA, the frequency
of mid-ventricular obstruction was 8 (38%). One patient showed
mid-ventricular obstruction in 226 HCM patients without LVAA.
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Fig. 1. Representation of electrocardiograms of hypertrophic cardiomyopathy patients with left ventricular apical aneurysm. (A) Patients 1, 17, and 18, showing an rS pattern
in V3 through V5, and convex ST-segment elevation. (B) Patients 4, 5, 6, 13, 19, and 20, showing normal R waves, convex ST-segment elevation, and negative T waves in V3
t vation
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Through V5. (C) Patients 3 and 12, showing high Rwaves, up-sloping ST-segment ele
waves, horizontal ST-segment elevation and positive T waves in V3 through V5. (
egative T waves. Note that leads V1 through V6 were recorded at one-half standar
his high event rate of aneurysm formation in patients with mid-
entricular obstruction suggests that prophylactic pharmacological
reatment ofmid-ventricular obstructionmight be consideredeven
n asymptomatic patients. There are some possibilities that cause
he variation in LVAA prevalence between our results and previous
eports. The ﬁrst possibility is the result of racial/ethnic differ-
nces. The second possibility is the selection bias of HCM patients.
he third possibility is that echocardiography has a limitation for, and negative Twaves in V3 through V5. (D) Patients 7, 11, and 14, showing normal
ients 2, 8, 9, 10, 15, 16, and 21, showing high R waves, ST-segment depression and
visualizing the apical portion of left ventricle, which causes under-
recognition or misdiagnosis.
Although it is important to identify LVAAs in HCM patients
and echocardiography is generally regarded as the standard ref-
erence technique, echocardiography seems to underestimate the
prevalence of apical aneurysms. This is likely due to several fac-
tors, including the apical aneurysm size and location, and the
poor quality of images from the apical window. ECG has major
M. Ichida et al. / Journal of Cardiology 64 (2014) 265–272 269
Fig. 2. (A) Patient 12, showing the 5-year electrocardiogram (ECG) follow-up in hypertrophic cardiomyopathy patient with left ventricular apical aneurysm. Top, left
ventricular hypertrophy and a precordial negative T wave. Bottom, ST-segment elevation in V3 through V6 was identiﬁed (arrows). (B) Patient 17, showing a 28-year ECG
follow-up. The reduction of the R wave amplitude and T wave negativity were recognized, along with ST-segment elevation in V3 through V5 (arrows).
270 M. Ichida et al. / Journal of Cardi
Table 2
Sensitivity, speciﬁcity, accuracy of ST-segment elevation and diastolic paradoxic
ﬂow to identify apical aneurysm in hypertrophic cardiomyopathy patients.
ST-
segment
elevation
Diastolic paradoxic
ﬂow
ST-segment
elevation and/or
diastolic paradoxic
ﬂow
Sensitivity (%) 66.7 42.9 81.0
Speciﬁcity (%) 98.7 99.6 98.2
PPV (%) 82.4 90.0 81.0
NPV (%) 97.0 94.9 98.2
PLR 50.2 96.8 45.7
NLR 0.34 0.57 0.19
P
f
F
P
d
pPV, positive predictive value; NPV, negative predictive value; PLR, likelihood ratio
or a positive ﬁnding; NLR, likelihood ratio for a negative ﬁnding.
ig. 3. Two-dimensional echocardiography images and continuousDoppler tracing of hyp
atient 1, showing LVAA formation in the 4-chamber view at end systole (arrowhead). (B)
iastolic paradoxic jet ﬂow from the apex to the mid portion of the LV (arrow). Left, at sys
eak ﬂow velocity of the diastolic paradoxic jet ﬂow (arrow) and the systolic ﬂow (arrowology 64 (2014) 265–272
advantages because it is readily available and a non-specialist can
often interpret the results. ECG can be conveniently used to eluci-
date the presence of abnormalities of the heart. The cause of this
high incidence of LVAA in our study was considered that the ECG
enhanced the diagnostic accuracy for detecting apical LVAAs in the
overall population of HCM patients.
Fourteen (66%) of the 21 HCM patients with LVAA showed
ST-segment elevation (Fig. 1). Four of the 21 HCM patients with
LVAA showed progression of ST segment elevation before detec-
tion of the apical aneurysm by echocardiography. Fig. 2B shows the
28-year ECG follow-up of patient number 17. The ST-segment ele-
vation in V3–V5 developed, and then the reduction of the R wave
amplitude and the T wave negativity was seen. It is strongly sug-
gested that ST-segment elevation (≥1mm) in V3 through V5 is
useful for early detection of aneurysm formation. Previous reports
demonstrated that the ECG of HCM patients with LVAA showed
ertrophic cardiomyopathypatientswith left ventricular apical aneurysm (LVAA). (A)
Patient 3, showing a color Doppler image in the apical long-axis viewdemonstrating
tole. Right, at diastole. (C) Continuous Doppler tracing showed the intraventricular
head). (D) Patient 7, showing a thrombus in the apical aneurysm (arrow).
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onvex ST-segment elevation (>1mm in >2 contiguous leads)
n V1 through V4, T-wave inversion without ST-segment eleva-
ion in V1 through V4 [8] and loss of giant T wave negativity
25].
The presence of a diastolic paradoxic jet ﬂow could be an impor-
ant marker of concealed apical asynergy and the risk of adverse
linical events [19]. In our study, 9 of 21 HCM patients with apical
neurysms showed a diastolic paradoxic jet ﬂow. In the 224 HCM
atients without LVAA, only one patient presented diastolic para-
oxic jet ﬂow. When the diastolic paradoxic jet ﬂow was used to
dentify LVAAs, it hada sensitivityof42.9%anda speciﬁcityof99.6%.
he use of ST-segment elevation led to a sensitivity of 66.7% and a
peciﬁcity of 98.7%. The sensitivity of ST-segment elevation in ECG
nd/or thediastolic paradoxicﬂow for identifying apical aneurysms
n HCM patients was 81.0%, and the speciﬁcity was 98.2% (Table 2).
hen the dilatation of the LV chamber and the LV aneurysmdevel-
pment reduces the pressure gradient in the LV, a Doppler study by
chocardiography is not able to show the acceleration ﬂow in the
V. Therefore, ST-segment elevation in ECG appears to be a more
recise and reliablemethod for detecting apical aneurysms in HCM
atients during follow-up (Table 2).
CMR imaging has a higher spatial resolution and detection
apacity compared to echocardiography [8]. CMR is a non-invasive
tandard method to assess LV morphology. CMR is not always
erformed in HCM patients and the applications of CMR are
imited, because arrhythmia, the presence of pacemakers and other
mplantable devices disturb the study. In our study, only 3 of 21
CM patients with LVAA had CMR and not 1 of 226 HCM patients
ithout LVAA. Among the three aneurysm patients who under-
ent CMR, each demonstrated thin-walled LV apical aneurysms
nd maximal LV wall thickening at mid-ventricular level. The ﬁrst
Table 1, Patient No. 3) of three patients showed late gadolinium
nhancement (LGE) in aneurysmal rim and ST-segment elevation.
he second (Table 1, Patient No. 8) showed diffuse LGE in aneurys-
al rim andmid portion of ventricular septum, and no ST-segment
levation. In the third patient (Table 1, Patient No. 19), ST-segment
levation was detected, but LGE was not performed. The mech-
nism of ST-segment elevation was unclear. However, there is a
ossibility that diffuse LGE, which is consistent with myocardial
brosis, at mid portion of LV is not consistent with ST-segment
levation.
The clinical course of our HCM patients with LVAA was vari-
ble. There were no sudden deaths or severe progressive heart
ailure. Five patients had VT/VF and ICD implantations and four had
mbolic strokes. The overall rate of adverse disease consequences
as 10.1%/y. This rate is the same as in a previous report and sig-
iﬁcantly higher than that reported in the general HCM population
6,11].
Two of our 21 HCM patients with LVAA (9.5%) developed global
ystolic dysfunction (i.e. EF <50%). This prevalence of LV dysfunc-
ion was lower than that of previous studies (i.e. 25%) but higher
han that in the general HCM population (3%) [6,26]. It is necessary
o consider the possibility that LV dysfunction can develop in these
atients.
The presence of LVAA in an HCM patient can also provide the
tructural basis for intracavitary thrombus formation. Four of our
1 study patients experienced thromboembolic events. In three of
hese fourpatientswith thromboembolic events, a LVapical throm-
us was unexpectedly found by echocardiography, and their heart
hythm was sinus rhythm at the time their stroke occurred. The
emaining patient had atrial ﬁbrillation and did not have a LV apical
hrombus. These four patients were prescribed warfarin after the
troke event. These observations suggest a potential role for pro-
hylactic warfarin anticoagulation, determined on a case-by-case
asis, in order to protect against embolic stroke in HCM patients
6].ology 64 (2014) 265–272 271
Maron et al. suggested that aneurysm formation (and the asso-
ciated transmuralmyocardial scarring)may itself represent a novel
risk marker for some HCM patients [6]. In our study, 5 (23.8%) of
the 21 HCM patients with LVAA had VT/VF and received an ICD. Six
(28.5%) showed non-sustained VT. These observations support the
idea that apical aneurysms are associated with a high incidence
of VT/VF, and that there should be selective recommendation of
prophylactic ICD implantation [27].
The mechanism responsible for the formation of LVAAs in HCM
patients remains unresolved, although several potential mecha-
nisms have been suggested, such as increased LV wall stress as
a result of midcavitary LV obstruction and elevated intracavitary
systolic pressure leading to chronic myocardial ischemia, myocar-
dial bridging of the left anterior descending artery, and genetic
predisposition [6,7,19,27–29]. Kitaoka et al. showed that serum
tenascin-C levelsmayprovideanewprognostic biomarker forheart
failure in patients with HCM [30]. Tenascin-C is an extracellular
matrix protein that plays an important role in the development of
the heart. Serum tenascin-C levels are related to LV remodeling.
Study limitations
Because this study was from a single institution, it was a rel-
atively small study, and the follow-up period was not long, the
results should be interpreted carefully. We described the preva-
lence of LVAAs in HCM patients and clariﬁed the clinical proﬁle
and prognosis in this subtype of HCM patients. Clinical complica-
tions, including arrhythmias (AF, VT/VF), embolic events, sudden
cardiac death, and progressive heart failure, were evaluated retro-
spectively. Therefore, further studies on the prevalence of LVAAs,
the clinical proﬁles, and the prognosis in HCM patients are needed.
Transthoracic echocardiography has a limitation for visualiz-
ing the apical portion, because the apical chamber is obscured
at end-systole. However, the resolving power of two-dimensional
echocardiography images has recently been improved (harmonic
mode and the high frame rate of sector B-mode images). There is
a possibility that this improvement may help to overcome such a
limitation.
Conventional arteriography or cardiac computed tomography
angiograms were performed in only 6 of our 21 HCM patients.
Although none of the patients in our study had any chest pain or
ischemic events, we cannot rule out the possibility that coronary
artery diseasewas responsible for the formation of LVAA. However,
in three of four patients with Q waves in V3 through V5, conven-
tional arteriography or cardiac computed tomography angiograms
showed that their coronary arteries were normal.
We could not perform the analysis of genetic mutation in
-myosin heavy chain gene and myosin-binding protein C gene.
Therefore, precise genetic mechanism remains unresolved.
Conclusion
HCM patients with LVAA are not rare in Japanese and detection
of LVAA is clinically important because they can cause seri-
ous cardiovascular complications. However, LVAA have remained
underappreciated only by echocardiography. Although CMR is con-
sidered to be the most effective technique for identiﬁcation of
LVAA, CMR cannot always be performed for HCM patients. The ST-
segment elevation in V3 through V5 of ECG is a useful marker for
early detectionof LVAA formation. To follow-up suchHCMpatients,
serial analysis of ECG is generally regarded as one of the good tech-
niques to detect LVAA.Competing interests
None.
2 f Cardi
F
C
a
a
R
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[72 M. Ichida et al. / Journal o
unding
None
ontributors
M.I. designed the study, performed the data collection, data
nalysis and wrote the manuscript and Y.N. helped collect and
nalyze the data. K.K. supervised the study.
eferences
[1] MarianAJ, RobertsR. Recent advances in themolecular genetics of hypertrophic
cardiomyopathy. Circulation 1995;92:1336–47.
[2] Niimura H, Bachinski LL, Sangwatanaroj S, Watkins H, Chudley AE, McKenna
W, Kristinsson A, Roberts R, Sole M, Maron BJ, Seidman JG, Seidman CE. Muta-
tions in the gene for cardiac myosin-binding protein C and late-onset familial
hypertrophic cardiomyopathy. N Engl J Med 1998;338:1248–57.
[3] Schwartz K, Carrier L, Guicheney P, Komajda M. Molecular basis of familial
cardiomyopathies. Circulation 1995;91:532–40.
[4] Maron BJ, Spirito P. Implications of left ventricular remodeling in hypertrophic
cardiomyopathy. Am J Cardiol 1998;81:1339–44.
[5] Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of
hypertrophic cardiomyopathy inageneralpopulationof youngadults. Echocar-
diographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk
Development in (Young) Adults. Circulation 1995;92:785–9.
[6] Maron MS, Finley JJ, Bos JM, Hauser TH, Manning WJ, Haas TS, Lesser JR, Udel-
son JE, Ackerman MJ, Maron BJ. Prevalence, clinical signiﬁcance, and natural
history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.
Circulation 2008;118:1541–9.
[7] Fighali S, Krajcer Z, Edelman S, Leachman RD. Progression of hypertrophic car-
diomyopathy into ahypokinetic left ventricle: higher incidence inpatientswith
midventricular obstruction. J Am Coll Cardiol 1987;9:288–94.
[8] Moon JC, Fisher NG, McKenna WJ, Pennell DJ. Detection of apical hypertrophic
cardiomyopathy by cardiovascular magnetic resonance in patients with non-
diagnostic echocardiography. Heart 2004;90:645–9.
[9] Bottini PB, Carr AA, Prisant LM, Flickinger FW, Allison JD, Gottdiener JS.
Magnetic resonance imaging compared to echocardiography to assess left ven-
tricular mass in the hypertensive patient. Am J Hypertens 1995;8:221–8.
10] Lorenz CH, Walker ES, Morgan VL, Klein SS, Graham Jr TP. Normal human right
and left ventricular mass, systolic function, and gender differences by cine
magnetic resonance imaging. J Cardiovasc Magn Reson 1999;1:7–21.
11] Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA
2002;287:1308–20.
12] McMahon CJ, Moniotte S, Powell AJ, del Nido PJ, Geva T. Usefulness ofmagnetic
resonance imaging evaluation of congenital left ventricular aneurysms. Am J
Cardiol 2007;100:310–5.
13] PaulM, SchafersM,GrudeM,ReinkeF, JuergensKU, FischbachR, SchoberO,Bre-
ithardt G, Wichter T. Idiopathic left ventricular aneurysm and sudden cardiac
death in young adults. Europace 2006;8:607–12.14] Toda G, Iliev II, Kawahara F, HayanoM, Yano K. Left ventricular aneurysmwith-
out coronary artery disease, incidence and clinical features: clinical analysis of
11 cases. Intern Med 2000;39:531–6.
15] Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum
H, Gutgesell H, Reichek N, Sahn D, Schnittger I, et al. Recommendations
[ology 64 (2014) 265–272
for quantitation of the left ventricle by two-dimensional echocardiography.
American Society of Echocardiography Committee on Standards, Subcom-
mittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc
Echocardiogr 1989;2:358–67.
16] Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left
ventricular hypertrophy in hypertrophic cardiomyopathy:morphologic obser-
vations and signiﬁcance as assessed by two-dimensional echocardiography in
600 patients. J Am Coll Cardiol 1995;26:1699–708.
17] Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. Magnitude of left
ventricular hypertrophy and risk of sudden death in hypertrophic cardiomy-
opathy. N Engl J Med 2000;342:1778–85.
18] Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, Cecchi F, Maron
BJ. Effect of left ventricular outﬂow tract obstruction on clinical outcome in
hypertrophic cardiomyopathy. N Engl J Med 2003;348:295–303.
19] Nakamura T, Matsubara K, Furukawa K, Azuma A, Sugihara H, Katsume H,
Nakagawa M. Diastolic paradoxic jet ﬂow in patients with hypertrophic car-
diomyopathy: evidence of concealed apical asynergy with cavity obliteration.
J Am Coll Cardiol 1992;19:516–24.
20] ErikssonMJ, Sonnenberg B,Woo A, Rakowski P, Parker TG,Wigle ED, Rakowski
H. Long-term outcome in patients with apical hypertrophic cardiomyopathy. J
Am Coll Cardiol 2002;39:638–45.
21] Sakamoto T, Tei C, Murayama M, Ichiyasu H, Hada Y. Giant T wave inversion
as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ven-
tricle. Echocardiographic and ultrasono-cardiotomographic study. Jpn Heart J
1976;17:611–29.
22] Yamaguchi H, Ishimura T, Nishiyama S, Nagasaki F, Nakanishi S, Takatsu
F, Nishijo T, Umeda T, Machii K. Hypertrophic nonobstructive cardiomy-
opathy with giant negative T waves (apical hypertrophy): ventriculographic
and echocardiographic features in 30 patients. Am J Cardiol 1979;44:
401–12.
23] Nasermoaddeli A, Miura K, Matsumori A, Soyama Y, Morikawa Y, Kitabatake
A, Inaba Y, Nakagawa H. Prognosis and prognostic factors in patients with
hypertrophic cardiomyopathy in Japan: results from a nationwide study. Heart
2007;93:711–5.
24] KuboT, KitaokaH,OkawaM,Hirota T,HoshikawaE,HayatoK, YamasakiN,Mat-
sumuraY, Yabe T, NishinagaM, Takata J, Doi YL. Clinical proﬁles of hypertrophic
cardiomyopathy with apical phenotype—comparison of pure-apical form and
distal-dominant form. Circ J 2009;73:2330–6.
25] Webb JG, Sasson Z, Rakowski H, Liu P, Wigle ED. Apical hypertrophic car-
diomyopathy: clinical follow-up and diagnostic correlates. J Am Coll Cardiol
1990;15:83–90.
26] Harris KM, Spirito P, Maron MS, Zenovich AG, Formisano F, Lesser JR, Mackey-
Bojack S, Manning WJ, Udelson JE, Maron BJ. Prevalence, clinical proﬁle, and
signiﬁcance of left ventricular remodeling in the end-stage phase of hyper-
trophic cardiomyopathy. Circulation 2006;114:216–25.
27] Matsubara K, Nakamura T, Kuribayashi T, Azuma A, Nakagawa M. Sustained
cavity obliteration and apical aneurysm formation in apical hypertrophic
cardiomyopathy. J Am Coll Cardiol 2003;42:288–95.
28] Wigle ED, Rakowski H. Hypertrophic cardiomyopathy: when do you diag-
nose midventricular obstruction versus apical cavity obliteration with a small
nonobliterated area at the apex of the left ventricle? J Am Coll Cardiol
1992;19:525–6.
29] Ando H, Imaizumi T, Urabe Y, Takeshita A, Nakamura M. Apical segmental
dysfunction in hypertrophic cardiomyopathy: subgroup with unique clinical
features. J Am Coll Cardiol 1990;16:1579–88.
30] Kitaoka H, Kubo T, Baba Y, Yamasaki N, Matsumura Y, Furuno T, Doi YL. Serum
tenascin-C levels as a prognostic biomarker of heart failure events in patients
with hypertrophic cardiomyopathy. J Cardiol 2012;59:209–14.
